120 related articles for article (PubMed ID: 9062478)
1. Visceral adipose tissue is associated with circulating high affinity growth hormone-binding protein.
Roelen CA; Koppeschaar HP; de Vries WR; Snel YE; Doerga ME; Zelissen PM; Thijssen JH; Blankenstein MA
J Clin Endocrinol Metab; 1997 Mar; 82(3):760-4. PubMed ID: 9062478
[TBL] [Abstract][Full Text] [Related]
2. Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults.
Fisker S; Vahl N; Jørgensen JO; Christiansen JS; Orskov H
J Clin Endocrinol Metab; 1997 Jan; 82(1):123-8. PubMed ID: 8989245
[TBL] [Abstract][Full Text] [Related]
3. High-affinity growth hormone (GH)-binding protein (GHBP), body fat mass, and insulin-like growth factor-binding protein-3 predict the GHBP response to GH therapy in adult GH deficiency syndrome.
Roelen CA; Koppeschaar HP; de Vries WR; Doerga ME; Snel YE; Bol E; Zelissen PM; Thijssen JH; Blankenstein MA
Metabolism; 1999 Mar; 48(3):314-8. PubMed ID: 10094106
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Growth Horm IGF Res; 1998 Apr; 8(2):105-12. PubMed ID: 10987677
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response.
Florkowski CM; Barnard R; Livesey JH; Veveris T; Espiner EA; Donald RA
Growth Horm IGF Res; 1999 Feb; 9(1):35-40. PubMed ID: 10207506
[TBL] [Abstract][Full Text] [Related]
6. Intersubject responsiveness of high-affinity growth hormone (GH)-binding protein (GHBP) to long-term GH replacement therapy.
De Vries WR; Koppeschaar HP; Bol E; Roelen CA; Donker GH; Doerga ME; Osman-Dualeh M; Snel YE
J Endocrinol Invest; 2000; 23(7):449-56. PubMed ID: 11005269
[TBL] [Abstract][Full Text] [Related]
7. GH-binding protein in obese men with varying glucose tolerance: relationship to body fat distribution, insulin secretion and the GH-IGF-I axis.
Nam SY; Kim KR; Song YD; Lim SK; Lee HC; Huh KB
Eur J Endocrinol; 1999 Feb; 140(2):159-63. PubMed ID: 10069661
[TBL] [Abstract][Full Text] [Related]
8. Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age.
Hansen TK; Jørgensen JO; Christiansen JS
J Clin Endocrinol Metab; 2002 May; 87(5):2185-93. PubMed ID: 11994362
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment.
Fisker S; Kristensen K; Rosenfalck AM; Pedersen SB; Ebdrup L; Richelsen B; Hilsted J; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 2001 Feb; 86(2):792-6. PubMed ID: 11158048
[TBL] [Abstract][Full Text] [Related]
12. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.
de Boer H; Blok GJ; Voerman B; Derriks P; van der Veen E
Int J Obes Relat Metab Disord; 1996 Jun; 20(6):580-7. PubMed ID: 8782736
[TBL] [Abstract][Full Text] [Related]
13. Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: roles of body weight and estrogen levels.
Bondanelli M; Margutti A; Ambrosio MR; Plaino L; Cobellis L; Petraglia F; degli Uberti EC
J Clin Endocrinol Metab; 2001 May; 86(5):1973-80. PubMed ID: 11344194
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year.
Fisker S; Vahl N; Hansen TB; Jørgensen JO; Hagen C; Orskov H; Christiansen JS
Metabolism; 1997 Jul; 46(7):812-7. PubMed ID: 9225837
[TBL] [Abstract][Full Text] [Related]
15. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
[TBL] [Abstract][Full Text] [Related]
16. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
Doehner W; Pflaum CD; Rauchhaus M; Godsland IF; Egerer K; Cicoira M; Florea VG; Sharma R; Bolger AP; Coats AJ; Anker SD; Strasburger CJ
Eur J Endocrinol; 2001 Dec; 145(6):727-35. PubMed ID: 11720897
[TBL] [Abstract][Full Text] [Related]
17. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.
Rietschel P; Hadigan C; Corcoran C; Stanley T; Neubauer G; Gertner J; Grinspoon S
J Clin Endocrinol Metab; 2001 Feb; 86(2):504-10. PubMed ID: 11158000
[TBL] [Abstract][Full Text] [Related]
18. Effect of growth hormone (GH) on serum concentrations of leptin: study in patients with acromegaly and GH deficiency.
Miyakawa M; Tsushima T; Murakami H; Isozaki O; Demura H; Tanaka T
J Clin Endocrinol Metab; 1998 Oct; 83(10):3476-9. PubMed ID: 9768649
[TBL] [Abstract][Full Text] [Related]
19. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
[TBL] [Abstract][Full Text] [Related]
20. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
